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Abstract 
Uncombable hair syndrome (UHS), also known as “spun glass hair syndrome”, “pili 
trianguli et canaliculi”, or “cheveux incoiffables” is a rare anomaly of the hair shaft 
which occurs in children and improves with age. UHS is characterized by dry, frizzy, 
spangly and often fair hair that is resistant to being combed flat. Up to date both 
simplex and familial UHS cases with autosomal dominant as well as recessive 
inheritance have been reported. However, none of these cases were linked to a 
molecular genetic cause. Here, we report the identification of UHS causative 
mutations located in the three genes PADI3 (peptidylarginine deiminase 3), TGM3 
(transglutaminase 3) and TCHH (trichohyalin) in a total of eleven children. All of these 
individuals carry homozygous or compound heterozygous mutations in one of these 
three genes, indicating an autosomal recessive inheritance pattern in the majority of 
UHS cases. The two enzymes PADI3 and TGM3, responsible for posttranslational 
protein modifications, and their target structural protein TCHH, are all involved in hair 
shaft formation. Elucidation of the molecular outcomes of the disease causing 
mutations by cell culture experiments and tridimensional protein models 
demonstrated clear differences in the structural organization and activity of mutant 
and wild type proteins. Scanning electron microscopy observations revealed 
morphological alterations in hair coat of Padi3 knockout mice. All together, these 
findings elucidate the molecular genetic causes of UHS and shed light on its 
pathophysiology, and hair physiology in general.  
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Introduction 
UHS [MIM 191480], was first described as a distinctive hair shaft defect in 1973.1; 2 
However, the phenotype had been recognized far earlier and had obtained notoriety 
as the famous literary character ‘Struwwelpeter-Shockheaded Peter’ from the 
children’s story published by the German physician Heinrich Hoffmann in 1845. This 
was later translated by Mark Twain to English as ‘Slovenly Peter’. Up to now about 
100 UHS cases have been reported.e.g. 3-5 Most of the cases are simplex occurrences 
but autosomal dominant or recessive inheritance patterns were also observed. In 
majority of the cases, UHS is an isolated condition of the hair, but it has occassionally 
been observed with additional symptoms, such as ectodermal dysplasias, 
retinopathia pigmentosa, juvenile cataract, and polydactyly. Isolated UHS is 
characterized by silvery, blond or straw colored scalp hair that is dry, frizzy and wiry, 
has a characteristic sheen, stands away from the scalp in multiple directions and is 
impossible to comb. This hair shaft disorder occurs in children and improves with 
age. The hair growth rate can range from slow to normal. The clinical diagnosis of 
UHS can be confirmed by scanning electron microscopy (SEM) analysis of hair 
shafts.6-8 In at least 50% of the hair examined, this reveals a triangular or heart-
shaped cross-section, in comparison to the normal circular cross section, as well as 
longitudinal grooves along the entire length of the hair shaft.9 The hair is not more 
fragile or brittle than normal hair. No effective therapy is yet available although biotin 
supplementation was reported to be successful in some cases.10  
Up to date no genetic alteration had been linked to UHS although familial occurrence 
has been well observed. In this study, we report UHS causative mutations in PADI3 
[MIM 606755], TGM3 [MIM 600238] and TCHH [MIM 190370], encoding for hair shaft 
proteins that display sequential interactions with each other. Transfection of cells with 
constructs encoding for wild type (WT) and mutant proteins showed that the identified 
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PADI3 and TGM3 mutations have profound effects on enzymatic activity of the 
respective proteins. The observation of alterations in whiskers and hair coat of Padi3 
knockout mice confirms the essential role of this enzyme in hair shaft morphology. 
Altogether, our findings implicate that UHS occurs when interactions of a structural 
protein that gives shape and mechanical strength to the hair shaft are impaired by 
defects either in this protein itself or in others that mediate its interactions.  
 
Materials and Methods 
Study participants 
Detailed information regarding the clinical descriptions of the individuals included in 
this study is given in the Supplemental Note: Case Reports. This study was 
performed according to the principles of the Declaration of Helsinki. Ethical approval 
was obtained from the ethics committee of the Medical Faculty of the University of 
Bonn and the participants provided written informed consent prior to blood sampling. 
Written informed consents of the affected individuals or their legal guardians were 
obtained for the publication of the case photos included in this manuscript. 
Scanning electron microscopy 
Hair shafts from various individuals with UHS and controls were mounted on stubs 
and sputter coated with either gold or platinum prior to examination in either a FEI 
Quanta FEG250 or a Philips 505 scanning electron microscope. 
Exome sequencing 
Exome sequencing was performed in two different centers. The two affected siblings 
of the discovery family from UK were exome sequenced by Oxford Gene 
Technology’s Genefficiency Sequencing Service. Genomic DNA (2 μg) was 
fragmented and enriched for human exonic sequences using the Human All Exon V5 
Agilent Sure Select kit (Agilent Technologies) using the manufacturers protocol, and 
6 
 
sequenced on the Illumina HiSeq 2000 platform using Truseq (v3 Chemistry) 
(Illumina) to generate 100 base paired-end reads. Fastq files were mapped to the 
reference human genome (hg19/GRCh37) using the Burrows-Wheeler Aligner (BWA) 
package (v0.6.2).11 Local realignment of the mapped reads around potential 
insertion/deletion (indel) sites was carried with the Genome Analysis Tool Kit (GATK) 
v1.6.12 Duplicate reads were marked using Picard v1.8 and BAM files were sorted 
and indexed with SAM tools v0.1.18.13 Approximately 12 and 14 GB of sequence 
data was generated for these samples and a minimum of 90.83% and 80.54% of the 
targeted exome was covered to a depth of at least 20× and 30× coverage, 
respectively. We filtered the variants for high-quality homozygous or potentially 
compound heterozygous, novel variants [defined against dbSNP 132 inclusion] that 
are shared by both siblings and are deleterious based on either of the SIFT, 
Polyphen and Condel predictions. 
The affected individuals from Germany and Turkey were exome sequenced at the 
Cologne Center for Genomics. For whole-exome sequencing, 1 μg of genomic DNA 
was fragmented with sonication technology (Bioruptor, Diagenode). The fragments 
were end-repaired and adaptor-ligated, including incorporation of sample index 
barcodes. After size selection, a pool of all 5 libraries was subjected to an enrichment 
process with the SeqCap EZ Human Exome Library version 2.0 kit (Roche 
NimbleGen). The final libraries were sequenced on an Illumina HiSeq 2000 
sequencing instrument (Illumina) with a paired-end 2× 100 bp protocol. Primary data 
were filtered according to signal purity by the Illumina Realtime Analysis (RTA) 
software v1.8. Subsequently, the reads were mapped to the human genome 
reference build hg19 using the BWA-aln alignment algorithm.11 GATK v.1.6 was used 
to mark duplicated reads, to do a local realignment around short insertions and 
deletions, to recalibrate the base quality scores and to call SNPs and short Indels.12 
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For the Turkish individual this resulted in 7.5 Gb of unique mapped sequences, a 
mean coverage of 94 and 30× coverage of 91% of the target sequences. For the 
German individual, this resulted in 8.1 Gb of unique mapped sequences, a mean 
coverage of 106 and 30× coverage of 92% of the target sequences. The Varbank 
pipeline v.2.10 and interface developed in-house at the Cologne Center for Genomics 
were used for data analysis and filtering (unpublished data, H.T., J.A., and P.N.). The 
GATK UnifiedGenotyper variation calls were filtered for high-quality (DP>15; AF>0.25 
+ VQSLOD >-8 if possible, otherwise: QD>2; MQ>40; FS<60; MQRankSum>-12.5; 
ReadPosRankSum>-8; HaplotypeScore <13) rare (MAF ≤ 0.005 based on 1000 
genomes build 20110521 and EVS build ESP6500) variants, predicted to modify a 
protein sequence or to impair splicing, in homozygous or compound heterozygous 
state. 
Sanger Sequencing  
Amplicons were generated under standard polymerase chain reaction conditions by 
using primers presented in Tables S1-S3. Sanger sequencing was performed using 
the BigDye Terminator v1.1 Cycle Sequencing kit (Applied Biosystems) and an ABI 
3100 genetic analyzer (Applied Biosystems). The data were analyzed using SeqMan 
II software (DNASTAR). 
Molecular cloning and mammalian cell cultures 
To construct the expression vectors for PADI3 and TGM3, the coding sequences 
(cDNA) of PADI3 (1995 bp) and TGM3 (2082 bp), were amplified from hair follicle 
cDNA, and cloned into the TOPO cloning site of pcDNA 3.1/V5-His-TOPO vector 
(Invitrogen) according to manufacturer’s protocol. The mutant constructs (PADI3: 
c.335T>A [p.Leu112His], c.881C>T [p.Ala294Val], c.1813C>A [p.Pro605Thr] and 
TGM3: c.1351C>T [p.Gln451*]) were generated by targeted mutagenesis using 
QuickChange II Site-Directed Mutagenesis kit (Agilent Technologies) according to 
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manufacturer’s instructions. The constructs were verified by Sanger sequencing. The 
primers used for cloning and mutagenesis are listed in Table S4. The HaCaT human 
keratinocyte cell line was established by Boukamp et al. (1988). 14 The HEK293T cell 
line was a kind gift from Thomas Zillinger (Institute of Clinical Chemistry and Clinical 
Pharmacology, University of Bonn). Both HaCaT and HEK293T cell lines were tested 
for mycoplasma contamination and confirmed to be mycoplasma free. Cells were 
maintained at 37oC (5% CO2) in DMEM (Lonza) supplemented with 10% FCS (Life 
Technologies), 1%  Penicilin- streptomycin (10,000 U ml-1, Life Technologies) and 1%  
Amphotericin B (250 µg ml-1, Life Technologies). Cells were cultured in 10 cm Petri 
dishes and on coverslips in 24-well plates for western blotting and 
immunofluorescence analysis, respectively. Transfections were carried on using the 
Lipofectamine3000 Transfection Kit (Life Technologies) according to manufacturer’s 
instructions. For each 10 cm plate, the following amounts of reagents were used: 15 
µg plasmid, 1500 µl Opti-MEM (Life Technologies), 22.5 µl Lipofectamine3000 and 
30 µl P3000 reagent. For each well in a 24-well plate, 0.5 µg of plasmid, 50 µl Opti-
MEM, 1.5 µl Lipofectamine3000 and 1 µl P3000 reagent were used. Cells were 
harvested 48 h post-transfection.  
Topological tridimensional models of PADI3 
We constructed, as we had previously published,15 a topological tridimensional model 
of WT PADI3 using the crystal atomic coordinates of calcium-bound human PADI4 
(MIM 605347; Protein Data Bank accession number 1WDA).16 On this basis, 
topological models of the tridimensional structure of the three mutated enzymes were 
produced after in silico substitutions of the respective amino acids. All the models 
were refined by energy minimization (3x3000 iterations) using the MSI insight II 
modules Biopolymer, CHARMM and Viewer on an O2 SGI station. Energetic 
potentials after minimization were all improved and validated. The three models were 
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then validated by analyses of “Anolea data” and Ramachandran plots produced using 
the Swiss model expasy structure assessment tools and the Swiss-Pdb viewer 
software version 4.04, respectively. Finally, topological models of mutated PADI3 
were individually compared to that of WT PADI3 after a magic fit on Swiss-Pdb 
viewer. Solid ribbon representations were displayed to show overviews of the 
tridimensional structures or enlargements focused on either the catalytic sites or the 
five calcium binding sites. 
Immunoblotting of HaCaT and HEK293T cell extracts  
Cells were collected in ice-cold PBS and centrifuged at 150 x g at 4°C for 10 min. 
The cell pellets were re-suspended in 40 µl of 10x RIPA buffer (Cell Signaling 
Technology) and 360 µl Protease Inhibitor Cocktail (Roche), incubated on ice for 15 
min and sonicated 10 times for 10 sec, with 10 sec breaks on ice. After centrifugation 
at 10,500 x g for 10 min at 4°C, the supernatants were transferred to clean tubes and 
purified with Micro Bio-Spin Columns (Bio-Rad Laboratories) according to 
manufacturer’s instructions. Purified lysates were mixed with 4x Laemmli sample 
buffer (Bio-Rad Laboratories) diluted in β-mercaptoethanol. After protein separation 
on TGX stain-free gels 4-15% (Bio-Rad Laboratories), the proteins were transferred 
on PVDF membrane (Amersham Biosciences). Western blotting was carried out 
using the WesternBreeze chemiluminescent kit (Invitrogen) according to 
manufacturer’s instructions. The following primary antibodies were used with an 
incubation duration of 1h: mouse monoclonal anti-V5 (1:5000, V8012, Sigma Aldrich) 
and rabbit monoclonal anti-PADI3 / PAD3 (1:400, ab172959, Abcam) for PADI3 
detection, mouse monoclonal anti-Flag (1:5000, F1804, Sigma Aldrich) and rabbit 
polyclonal anti TGM3-C-terminal (1:250, OAAB12971, Aviva Systems Biology) for 
TGM3 detection. Membranes were developed using the ChemiDoc MP imager (Bio 
Rad) for a maximum of 20 min. Data in Figure 4A are representative of western 
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blotting experiments from three independent transfections of HaCaT cells with PADI3 
constructs. Data in Figure 7A and Figure S7 emerge from six independent 
transfections of HaCaT (1x) and HEK293T (5x) cells with TGM3 constructs. The 
relative quantities of WT and mutated TGM3 were assessed using Stain-Free 
technology that is based on total protein normalization (Bio-Rad Laboratories).17  
Immunofluorescence analysis in HaCaT and HEK293T cells  
Transiently transfected HaCaT and HEK293T cells grown on coverslips were washed 
with 1x PBS for 5 min, permeabilized for 10 min with 1% Triton X-100 and blocked for 
1h in PBS containing 1% bovine serum albumin, 10% normal goat serum and 0.1% 
Triton X-100. The cells were incubated with mouse monoclonal anti-V5 primary 
antibody (1:100, V8012, Sigma Aldrich) or mouse monoclonal anti-Flag antibody 
(1:500, F1804, Sigma Aldrich) for PADI3 and TGM3, respectively, for 3h at RT (or 
overnight at 4oC) and goat anti-mouse-cy3 secondary antibody (1:500, A10521, Life 
Technologies) with DAPI (D9542, Sigma Aldrich) for 40 min. The mounting was 
performed with Mowiol 4-88 (Roth). Images were captured with 63x or 10x oil 
immersion objectives using a Zeiss Axioplan 2 imaging microscope and the 
Cytovision 7.4 software. ImageJ was used for the analyses by applying the same 
brightness and contrast thresholds to all data. Data presented in Figure 4B and 
Figure 7B are representative of analyses from four independent transfections of 
HaCaT cells with PADI3 constructs and five independent transfections of HaCaT (3x) 
and HEK293T (2x) cells with TGM3 constructs, respectively. Two to three coverslips 
were analyzed per construct at each transfection.  
Activity of PADI3 in HaCaT cells 
Transiently transfected HaCaT cells grown on coverslips were air-dried. For indirect 
immunofluorescence, the cells were rehydrated for 15 min in PBS and permeabilized 
for 10 min in PBS containing 1% Triton X-100, and then non-specific binding sites 
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were blocked with PBS containing 2% fetal bovine serum and 1% Triton X-100. 
Slides were incubated with the following primary antibodies: mouse monoclonal anti-
V5 (1:100, R960-25, Thermo Fisher Scientific) and ACPA antibodies (6 µg ml-1) 
purified from a pool of sera of individuals affected by rheumatoid arthritis [MIM 
180300].18; 19 Sera were from informed and consenting individuals attending the 
Rheumatology Center of Toulouse and have been declared to and approved by the 
Comité de Protection des Personnes Sud Ouest et Outre-Mer II (Toulouse, France). 
After incubation with the corresponding secondary antibodies, Alexa Fluor 488 
Donkey anti-mouse IgG (1:10000, A21202, Thermo Fisher Scientific), Alexa Fluor 
555 Goat Anti-human IgG (H+L) (1:10000, A21433, Thermo Fisher Scientific), and 
DAPI (D9542, Sigma-Aldrich), slides were mounted in Mowiol 4-88 (Calbiochem 
Merck Millipore). Images were captured with 20x dry or 63x oil immersion objectives 
using a Zeiss apotome microscope (Carl Zeiss). ImageJ was used for the analyses 
by applying the same brightness and contrast thresholds to all data. Data presented 
in Figure 5A are representative of analyses from two independent transfections of 
HaCaT cells with three coverslips for each single PADI3 construct.  
Activity of PADI3 produced in Escherichia coli  
E coli strain BL21(DE3)-pLysS (Life Technologies) were transformed with 5 ng of the 
recombinant expression plasmids (pcDNA3.1/V5-His-TOPO–PADI3-WT, 
pcDNA3.1/V5-His-TOPO–PADI3-p.Leu112His, pcDNA3.1/V5-His-TOPO–PADI3-
p.Arg294Val and pcDNA3.1/V5-His-TOPO–PADI3-p.Pro605Thr) and grown at 37°C 
overnight on agar-Luria Broth plates (MP Biomedicals) supplemented with ampicillin 
(50 µg ml-1) and chloramphenicol (34 µg ml-1). Four clones were selected for each 
plasmid. After selection, the bacterial clones were grown in Luria Broth medium 
supplemented with ampicillin (50 µg ml-1), at 37°C for 3 hours and then overnight at 
30°C. Harvested bacteria were sonicated 4x8 seconds (6~10W) on ice in a Tris-HCl 
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pH 7.6 buffer containing a cocktail of bacterial protease inhibitors (Sigma Aldrich). 
After centrifugation at 9,000 x g for 10 min, soluble proteins were recovered in the 
supernatants (clarified extracts).  
To measure an in vitro deimination activity, the clarified extracts were incubated at 
37°C in 100 mM Tris-HCl pH 7.6 buffer containing 10 mM CaCl2 and 5 mM DTT, for 
either 2 hours or overnight, under agitation at 1400 rpm.20 The deimination reactions 
were stopped by boiling for 3 min in Laemmli’s sample buffer. The proteins were then 
separated by SDS-polyacrylamide (10%) gel electrophoresis and immunodetected 
with the V5 Epitope Tag monoclonal antibody (1:5000, R960-25, Thermo Fisher 
Scientific) and the anti-modified citrulline antibodies.21; 22 The blots were developed 
using the ECL primeTM system (GE Healthcare) as described by the manufacturer. 
Immunoblotting signals were recorded using a G:BoxTM Chemi XT4 imager and 
GeneTool analysis software (Syngene) for a maximum of 20 min.  
After one bacteria transformation, two independent clones for p.Leu112His, three for 
p.Pro605Thr and four for WT and p.Ala294Val were analyzed, with identical results; 
only those corresponding to two clones are illustrated. Data are representative of two 
technical replicates. The V5-antibody detections of recombinant PADI3 were 
confirmed using an anti-PADI3 antibody.22 
Padi3-deficient mice 
All experiments with animals were approved by a local ethic committee (INSERM 
US006 CEEA-122) and carried out according to our Institution guidelines and EU 
legislation. Padi3-deficient mice (B6NCrl;B6N-Atm1BrdPadi3tm1a(KOMP)Wtsi/Or, 
abbreviated to Padi3tm1a) were generated by the Phenomin Program at the ICS 
Laboratory (Strasbourg, France). A promoter-less LacZ-reporter cassette containing 
a neomycin-resistance gene and flanked by two flippase recognition target sites was 
inserted between exons 4 and 5 of the Padi3 gene, with loxP sites flanking the exons 
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5 and 6. See http://www.mousephenotype.org/data/search/gene?kw=padi3 for more 
details. Mice were maintained in the TAAM animal facility (CNRS UPS44, Orléans, 
France) under pathogen-free conditions. They were killed by cervical dislocation. All 
efforts were made to minimize suffering. The following oligonucleotides were used for 
genotyping: Padi3 forward (5′-CTTTATTGATAAACACAGGCAGGGAGC-3′), Padi3 
reverse (5′-CAATGGAATCCCTCTGTCCCTCACC-3′), and LacZ reverse (5’-
CCAACAGCTTCCCCACAACGG-3’). A wild type PCR product of 241 bp and a tm1a 
allele product of 365 bp were produced. Genotyping was confirmed using the Padi3 
forward (5‘-CCCTCTTTGAGGACCACAGGCTTATC-3’) and reverse (5’-
GCACTCAAGAAGCAGAGGCAGGC-3’) primers, a wild type PCR product of 369 bp 
and a tm1a allele product of 421 bp were produced. No randomization was used. The 
SEM observations of whiskers and hair coat were done in blind, by two independent 
scientists. 
Transglutaminase activity of TGM3  
In order to compare the enzymatic activity of WT and mutant TGM3 in cell extracts of 
transiently transfected HEK293T cells we adapted the transglutaminase assay 
described by Aufenvenne et al. (2009).23 This assay is based on the incorporation of 
monodansylcadaverine into casein by transglutaminase, which causes an 
augmentation of fluorescence and an emission wavelength shift. Lysates of cells 
transiently transfected with WT or mutant TGM3 constructs were prepared 48 h post-
transfection as described in the immunoblotting section. Lysates of mock-transfected 
cells were used as a negative control. The translation of the target proteins was 
always confirmed by immunoblotting. For the assay, the lysates were incubated for 
15 min in pre-warmed assay buffer (50 mM Tris/HCl, 10 mM CaCl2, 10 mM reduced 
glutathione, 2.5% glycerol, 2.5% DMSO, 25 µM monodansylcadaverine, 20 mM N,N-
dimethylcasein, pH 8) at 37°C. Measurements were then made for 10 min at 37°C 
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using a LS55 fluorescence spectrometer (Perkin Elmer) with excitation and emission 
wavelengths of 332 nm and 500 nm, respectively, and a 5.0 nm slit. The linear slopes 
of the measurements from technical triplicates of samples emerging from five 
independent transfections were used as a measure of the transglutaminase activity.23 
The activity data were not normally distributed (P < 0,050, Shapiro-Wilk) and 
analyzed by a Kruskal-Wallis test (One Way ANOVE on Ranks) with post hoc Dunn's 
pairwise multiple comparisons test. 
 
Results 
Identification of mutations in PADI3, TGM3 and TCHH 
In this study, we identified UHS causative mutations in three functionally related 
genes in a total of 11 individuals/families (Figure 1, Table 1 and Supplemental Note: 
Case Reports). The first family originated from the U.K. and had two affected and two 
unaffected siblings. The affected individuals reported typical hair problems in 
childhood with improvement while growing older (Figure 1J); gross and scanning 
electron microscopy observations were in line with an UHS phenotype (Figure 1K-L). 
In order to elucidate the genetic background of UHS in this family, we performed 
whole exome sequencing (WES) in both of the affected siblings. We filtered the data 
for novel and deleterious homozygous or potentially compound heterozygous 
variants that are shared by the siblings and identified a homozygous missense 
variant c.881C>T (p.Ala294Val) within PADI3 (GenBank: NM_016233.2). The 
mutation co-segregated with the disease phenotype in the family (Figure 2A, Figure 
S1).  
Then, we Sanger sequenced PADI3 in seventeen additional cases and detected the 
above mentioned mutation as well as two other recurrent missense mutations, 
c.335T>A (p.Leu112His) and c.1813C>A (p.Pro605Thr), in seven other 
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individuals/families (Table 1, Figure 2B-C, and Figure S2).24; 25 We also identified an 
individual who carries c.881C>T (p.Ala294Val) and a nonsense mutation, c.1732A>T 
(p.Lys578*), that occurred only once in our UHS cohort (Table 1, Figure 2B-C and 
Figure S2). These mutations were observed either in homozygous state or in 
compound heterozygosity as confirmed by parental DNA sequencing in three of the 
families (Figure S1). The allele frequencies of the PADI3 substitutions from Exome 
Aggregation Consortium (ExAC) data are presented in Table S5. The nonsense 
mutation was not observed in ExAC.  
As a next step, we performed WES in four further UHS cases with no PADI3 
mutations. We identified the nonsense mutation c.1351C>T (p.Gln451*) in TGM3 
(GenBank: NM_003245.3) in a Turkish individual26 and the nonsense mutation 
c.991C>T (p.Gln331*) in TCHH (GenBank: NM_007113.3) in a German individual 
(Figure 2D-G;  Table S5). No homozygous loss of function mutations were observed 
in TGM3 or TCHH in ~60,000 sequenced individuals of the ExAC database. 
PADI3, TGM3 and TCHH interplay in hair shaft formation 
PADI3, a gene of the PADI family (PADI1-4 and 6), encodes the 664-amino acid 
peptidylarginine deiminase type III (Enzyme Commission number, EC.3.5.3.15).27 
This posttranslational modification enzyme converts positively charged L-arginine 
residues of proteins into neutral citrulline residues in the presence of calcium ions. 
The process is called deimination or citrullination. PADI3 is mainly detected in skin, 
including hair follicles where it modifies hair shaft proteins.28; 29 Although the enzyme 
has already been a focus of interest in hair biology, it could not be linked to any 
disorder until now. TGM3 encodes transglutaminase 3, a member of the 
transglutaminase family (EC.2.3.2.13), which catalyzes the calcium-dependent 
formation of isopeptide bonds between glutamine and lysine residues in various 
proteins including the archetypal hair shaft protein trichohyalin, encoded by TCHH. 
16 
 
TCHH is a structural protein co-localized with PADI3 in the inner root sheath of the 
hair follicle and in the medulla of the hair shaft. Deimination by PADI3 reduces the 
overall charge of TCHH, and that enables its association with the keratin intermediate 
filaments (KIF). Then, TCHH and KIF are crosslinked together by TGM3. KIFs are 
then stabilized, hardened and linked to cornified envelopes through further 
crosslinking by transglutaminases, particularly by TGM3 (Figure 2H).30-32 Thereby, 
TCHH and its sequential modifications by PADI3 and TGM3 have a very important 
role in shaping and mechanical strengthening of the hair. Of note, the TCHH mutation 
we identified leads to the synthesis, if any, of a very short protein, probably without 
any function in KIF interaction as the KIF interacting domain would be almost entirely 
missing (Figure 2G).  
Missense mutations in PADI3 affect the 3-D enzyme structure  
We next investigated the consequences of PADI3 mutations on the corresponding 
proteins. The p.Lys578* is expected to induce the synthesis of a truncated protein 
lacking the 87 amino acids of the carboxy terminal, in particular the Cys646 (Figure 
2C,  Table S6) absolutely necessary for the enzyme activity.28 Intriguingly, we 
observed that the three PADI3 amino acids substituted as a result of the missense 
mutations correspond to residues that are conserved in the five human PADI 
proteins, and also in the PADI3 from other species, suggesting they have an 
important role (Figure S3). However, none of them is directly involved in the catalytic 
site or in one of the five calcium-binding sites of PADI3 (Table S6). Nevertheless, 
when we analyzed the effect of the PADI3 missense mutations on the predicted 
three-dimensional structure of the enzyme,15 the mutations p.Ala294Val and 
p.Pro605Thr were shown to induce clear modifications of beta-sheets and alpha-
helices, in particular in the immunoglobulin-like NH2 domains, and also around the 
catalytic site and the calcium-binding sites. The effects of the p.Leu112His 
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substitution were less drastic (Figure 3 and Figures S4, S5).  
Aggregation and reduced enzymatic activity of PADI3 mutants  
We then cloned the wild-type WT PADI3 cDNA into a mammalian expression vector 
in order to induce the translation of a C-terminally V5-tagged PADI3 protein. Mutant 
constructs with the three recurrent missense mutations were generated by targeted 
mutagenesis. HaCaT cells were transiently transfected (5-10% transfection 
efficiency) with constructs encoding for WT and mutant forms of PADI3. 
Immunoblotting of cell extracts showed that all of the constructs led to translation of a 
protein of about 70 kDa (Figure 4A). The subcellular location of WT and mutated 
proteins was determined by immunofluorescence analyses that showed, as 
expected, a diffuse homogenous cytoplasmic distribution of the WT PADI3,22 
whereas in all three mutants the proteins were observed to form large aggregates 
throughout the cytoplasm (Figure 4B). To assess the enzymatic activity of WT and 
mutated PADI3, we performed double immunostaining with an anti-V5 monoclonal 
antibody and with human anti-citrullinated protein autoantibodies (ACPA) from 
individuals with rheumatoid arthritis, these antibodies specifically detecting 
citrullinated proteins.18; 33 While translation of the WT PADI3 resulted in a strong 
labeling with the ACPA antibodies, the signal in the cells producing the mutant 
proteins was barely above background (Figure 5A). We also produced the WT and 
mutant PADI3 in E. coli. After incubation of the WT PADI3-containing bacterial 
extracts with calcium for two hours, deiminated proteins were detected. By contrast, 
when the extracts containing the mutated PADI3 were incubated for two hours, and 
even up to eighteen hours, no deiminated proteins were detected (Figure 5B and 
Figure S6). Altogether, the results suggested that the mutated forms of PADI3 are 
either not or only weakly active.  
Padi3 knockout mice show whisker and hair anomalies 
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In order to demonstrate the importance of PADI3 in hair shaft formation and 
structure, we generated Padi3 knockout mice (Figure 6A-B). Breeding mice 
heterozygous for the Padi3tm1a mutation produced offspring with the three possible 
genotypes at the expected Mendelian ratios, showing that absence of Padi3 is 
compatible with life. Grossly, the skin of 7-weeks old null mice appeared normal. A 
further characterization by SEM revealed alterations in the morphology of hair coat 
(Figure 6C) and, less markedly, of whiskers. The surface of the lower (proximal) part 
of the vibrissae and the hairs on their entire length were irregular and rough and 
appeared as hammered. 
Nonsense mutation in TGM3 leads to reduced enzymatic activity 
We cloned the WT TGM3 cDNA into a mammalian expression vector in order to 
induce the translation of an N-terminally FLAG-tagged TGM3 protein. Mutant 
construct was generated by targeted mutagenesis. HaCaT and HEK293T cell lines 
were transiently transfected with WT and mutant TGM3 encoding constructs. WT 
TGM3 construct led to translation of a protein of about 70 kDa, while the nonsense 
mutation resulted in a truncated protein of around 40 kDa with a lower detection level 
(Figure 7A and Figure S7). Immunofluorescence analysis showed that TGM3 is 
located in the cytoplasm and that the truncated form is present in a dramatically lower 
number of cells (Figure 7B) in accordance with the western blot results. Generally 
these cells had a smaller cytosolic surface area in comparison to those producing the 
WT TGM3 (Figure 7B). We performed a transglutaminase activity assay23 with 
HEK293T cell lysates containing WT and mutated TGM3. The analysis results 
revealed that the WT had a significantly higher transglutaminase activity in 
comparison to the truncated protein and the latter did not differ from the mock 
transfected negative control (Figure 7C and Figure S8).  
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Discussion 
In this study we identified disease causative mutations for UHS in PADI3, TGM3 and 
TCHH with the former two genes encoding for posttranslational modification enzymes 
that act on the structural hair protein trichohyalin encoded by the latter gene. Our cell 
culture data show that the identified mutations in PADI3 and TGM3 lead to reduced 
or no enzymatic activity and the phenotype of the Padi3 knockout mice we generated 
show structural alterations in the whiskers and hair coat morphology. Our findings are 
also supported by the phenotype of the already existing Tgm3 knockout mice. These 
mice exhibit irregular, twisted whiskers and, at birth, have a wavy hair coat, which 
improves four weeks after birth.34 Scanning and transmission electron microscopy 
analyses of hairs from adult Tgm3-/- mice reveal alterations such as irregular torsions, 
deformed grooves, abnormal cuticle and shorter KIF.34 It is also convincing that, both 
nonsense and missense mutations in the Tgm3 gene are responsible for the 
wellhaarig mouse phenotype, named for the curly whiskers and wavy coat of the 
mutant animals.35 Based on the phenotype of the Tgm3-/- mice, John et al. have 
suggested that alterations in TGM3 or its substrates could be related to recessive 
forms of pili torti [MIM 261900] or similar hair phenotypes, which improve with age.34 
Our findings validate this hypothesis and furthermore identify UHS as the hair 
phenotype related to alterations not only in TGM3 but also in the other proteins of the 
TCHH-PADI3-TGM3 cascade. In some affected individuals, TCHH would not be 
produced, or produced as a truncated form unable to interact with KIF; in others, 
because of a PADI3 activity defect, TCHH would remain insoluble preventing its 
interaction with KIF; in the last group, TCHH/KIF interaction would not be stabilized 
by TGM3-mediated crosslinks. Taken together, this suggests that one of the 
particular processes in hair shaft formation that leads to UHS when disturbed might 
be the interaction of TCHH and KIF. This interaction is known to be crucial for 
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shaping and mechanical strengthening of the hair shaft. These findings also show 
that the compromise of any one of the proteins that play a role in this process would 
be enough to lead to the same phenotype.  
It is intriguing that, despite the defects affecting a structural component of the hair 
shaft, the phenotype in UHS is commonly reported to improve with age, similar to the 
hair coat phenotype of Tgm3-/- mice. Interestingly, improvement with age has also 
been observed in other hair shaft disorders (e.g. pili annulati, pili torti). The 
improvement in UHS might be due to the compensatory expression of another 
isoform of peptidylarginine deiminase, transglutaminase or other structural hair shaft 
components. On the other hand, aging related changes in hair follicles such as 
increase in diameter and length can have mechanistic influences that might account 
for this improvement.  
TGM3 and PADI3 are strongly detected in the upper epidermis. Nevertheless, no 
anomalies have been reported in the interfollicular epidermis of individuals with 
isolated UHS. Similarly, Tgm3-/- mice show no obvious skin defects.34 This is probably 
due to the fact that other isoforms of these enzyme families are present in the 
epidermis, which can compensate for the loss of PADI3 and TGM3 activity, whereas 
these two are the only isoforms detected in the hair cuticles and medulla.27; 28; 30 
Up to now, both simplex and familial cases of UHS have been reported with 
suggested autosomal dominant and recessive inheritance with variable levels of 
penetrance. In this study we consistently observed an autosomal recessive 
inheritance pattern in a total of 11 familial and simplex cases. Based on the 
pedigrees reported in literature, it is most likely that autosomal dominant forms of this 
condition exist7; 36; 37 which might be underlined by defects in other genes involved in 
hair shaft formation and maintenance related processes. It would be of interest then 
to investigate closely whether differences could be observed in the phenotypes of 
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these individuals in comparison to the individuals who carry recessive mutations in 
PADI3-TCHH-TGM3 cascade.   
An interesting observation was that, 5 out of 60,659 individuals in ExAC are 
homozygous for c.881C>T (p.Ala294Val). UHS is a non-debilitating phenotype that 
resolves with age and therefore, it is likely that these presumably affected individuals 
had participated in the ExAC project as "healthy" controls. This data also indicates 
that UHS is a more common phenotype than estimated.  
In summary, we elucidated the molecular genetic background of UHS by identifying 
recessive mutations in PADI3, TCHH and TGM3. The three genes encode for 
proteins that play an essential role during hair shaft formation through their sequential 
interactions. This finding, in combination with the data describing the functional 
effects of the mutations in PADI3 and TGM3, provides valuable information regarding 
the pathophysiology of UHS. Furthermore, it contributes to a better understanding of 
the protein interaction cascades in molecular histogenesis of the hair. This could be 
of further value for cosmetics and pharmaceutics industries paving the way for 
development of novel products. 
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Figure Legends  
Figure 1. Clinical appearance of UHS 
(A-G) Clinical presentation of UHS. Typical signs of UHS can be observed in (A-C) 
three German girls, (D) a German boy, (E) a Swiss boy, and (F-G) a Danish girl, who 
were included in the study. (G) The improvement of the phenotype with aging can be 
observed in the Danish girl. (H) SEM image of the Danish girl’s hair shaft showing the 
longitudinal groove (I) in comparison to a normal hair shaft. (J) The improved hair 
phenotype at age 15 and (K-L) the SEM findings of the male sibling from the UK 
family. (K) Longitudinal grooves and (I) heart-shaped cross section of hair presented 
(M) in comparison to the circular cross section from a control hair shaft, are indicative 
of UHS. Detailed information regarding the clinical histories can be found in the 
Supplemental Note; Case Reports.  
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Figure 2. Mutations causing UHS and interplay of PADI3, TGM3 and TCHH  
(A) The homozygous c.881C>T (p.Ala294Val) mutation in PADI3 identified by exome 
sequencing in the UK siblings was verified by Sanger sequencing. The mutation co-
segregates with the UHS phenotype in the pedigree as shown in Figure S1. (B) 
Electropherograms show the PADI3 mutations c.335T>A (p.Leu112His), c.1813C>A 
(p.Pro605Thr) and c.1732A>T (p.Lys578*) in comparison to the wild type sequences. 
(C) Schematic representation of PADI3 showing the various domains of the protein, 
the positions of calcium-binding sites (*), and of major amino acids involved in the 
catalytic sites (v). The positions of the substitutions responsible for UHS are indicated 
by an arrow. (D) Electropherograms show the homozygous TGM3 mutation 
c.1351C>T (p.Gln451*) identified in the Turkish male in comparison to the wild type 
sequence. (E) Schematic representation of TGM3. (F) Electropherograms show the 
homozygous TCHH mutation c.991C>T (p.Gln331*) identified in the German female 
in comparison to the wild type sequence. (G) Schematic representation of TCHH. (H) 
Cartoon depicting the cascade of interactions between TCHH, PADI3 and TGM3 in 
hair shaft biology. In trichohyalin granules (grey areas), TCHH appears as a dimer 
with a long rod-shaped domain and a globular end domain. After deimination by 
PADI3, TCHH is less structured, and the granules progressively dissolved. 
Citrullinated-TCHH (TCHH-Cit) interacts with keratin intermediate filaments (black 
lines) organizing them, and becomes a substrate for TGM3. Cross-links of TCHH to 
itself (intra- or inter-chains), to keratins and between keratins and the cornified cell 
envelope components are then catalyzed (green dash). 
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Figure 3. Topological tridimensional models of WT and mutant PADI3 
(A) Overall view of the tridimensional solid-ribbon representation of calcium-bound 
WT and three mutant PADI3 models. The tridimensional solid residues Leu112, 
Ala294 and Pro605, with their respective lateral chains, are reported on the proposed 
model of the WT enzyme, as well as the corresponding substituted amino acids on 
the model of each mutant, p.Leu112His, p.Ala294Val and p.Pro605Thr. The four 
amino acids involved in the catalytic site are also shown. According to these models, 
the p.Ala294Val and p.Pro605Thr substitutions induce a profound disorganization of 
the predicted immunoglobulin-like domains, with disappearance of several beta-
sheets, and modification of some alpha-helices of the catalytic domain, as compared 
to the WT. The effect of the p.Leu112His substitution is more discrete. (B) Zoom on 
the major amino acids involved in the catalytic site. Its proposed structure is clearly 
modified after p.Ala294Val and p.Pro605Thr substitutions. It should be noted that 
none of the substituted amino acids are directly involved in this site. 
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Figure 4. WT and mutant forms of PADI3 produced in HaCaT cell line. 
(A) Immunoblotting analysis shows the translation of WT and mutant PADI3 in 
transiently transfected HaCaT cells, which were collected 48 h post-transfection. 
Immunoblotting was performed with anti-V5 and anti-PADI3 antibodies. Antibody-
specific bands are indicated with an arrow and a non-specific cross-reactive band 
around 55 kDa is indicated with an asterisk. Full length blot images can be seen in 
Figure S9. (B) Immunofluorescence analysis in HaCaT cells transiently transfected 
with WT and mutant PADI3 encoding plasmids shows the homogeneous cytosolic 
localization of WT PADI3 whereas the three mutant proteins are observed in the form 
of large aggregates. Scale bars, 10µm. 
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Figure 5. Consequences of PADI3 mutations on the enzyme activity. 
(A) Indirect immunofluorescence analysis of transfected HaCaT cells. HaCaT cells 
were double labeled with anti-V5 monoclonal antibody (green) and ACPA antibodies 
(red). Nuclei were labeled with DAPI (blue). Scale bars, 10 µm. The WT PADI3 is 
clearly active (merge image; yellow color) whereas the mutants display a low activity. 
(B) WT PADI3 (bacterial clones 1 and 2) and the mutant forms, p.Leu112His (clones 
7 and 8), p.Ala294Val (clones 11 and 12) and p.Pro605Thr (clones 14 and 15), 
produced in E. coli, were extracted in Tris-HCl buffered salt. Soluble proteins were 
incubated for the indicated period of time (t; in hours) with calcium, separated by 
electrophoresis, transferred to membranes, stained with Ponceau Red and 
immunodetected with either the anti-modified citrulline rabbit antibodies or anti-V5 
antibody. While citrullinated proteins were detected when the WT-containing extracts 
have been incubated for two hours, no citrullinated proteins were detected in the 
mutant-containing extracts, even after 18 hours of incubation. The substituted 
enzymes appear to be cleaved and a V5-reactive doublet is observed. Molecular 
mass markers are indicated on the right in kDa. Full length blot images can be seen 
in Figure S9.  
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Figure 6. Padi3 gene disruption in mice. 
(A) Schematic representation of the Padi3 gene and the targeting vector. The exons 
are shown by numbered grey rectangles. A cassette containing the beta-
galactosidase (LacZ) and neomycin (neo) genes is inserted between exons 4 and 5. 
This results in the production of a truncated Padi3 protein corresponding to amino 
acids 1-136 fused to β-galactosidase. The position of the inserted loxP and flippase 
recognition target (FRT) sites are indicated, as well as the splicing acceptor site (SA) 
and the polyadenylation sites (pA) of LacZ and neo. The positions of the 
oligonucleotides (dashes) used for genotyping are shown, as well as the length of the 
amplified PCR products in wildtype (Padi3wt) and targeted (Padi3tm1a) alleles. (B) 
PCR on genomic DNA from tail biopsies of 10 mice from the same littermate (five 
females, 1-5, and five males, 6-10) showing amplification of the 241 bp fragment for 
the Padi3wt allele and the 365 bp fragment for the Padi3tm1a allele. (C) 
Representative pictures of SEM analysis of back hair coat from the three wt and 
three Padi3tm1a/tm1a mice (7 weeks old). Most hairs of the knockout mice are 
rough, with an irregular surface (white arrows). This is evident for thick hairs (top and 
middle micrographs), but was also observed for thin hairs (bottom). In some cases 
the hairs are twisted. The boxed areas are enlarged in the middle. At least six 
vibrissae and 200 hairs were analyzed per animal. Scale bar = 50 µm. 
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Figure 7.  WT and mutant forms of TGM3 produced in HaCaT and HEK293T cell 
lines 
(A) Immunoblotting analysis shows the translation of WT and truncated TGM3 in 
transiently transfected HaCaT cells, collected 48 h post-transfection. Immunoblotting 
was performed with anti-Flag and anti-TGM3 antibodies. Antibody-specific bands 
showing the WT (~70 kDa) and truncated TGM3 (~40 kDa) are indicated with an 
arrow and a non-specific cross-reactive band around 55 kDa is indicated with an 
asterisk. The truncated TGM3 can only be detected with the antibody against the 
Flag epitope fused to the N-terminus and not with the antibody against the C-
terminus of TGM3 as expected. Full length blot images can be seen in Figure S9. 
Immunoblotting analysis with HEK293T cells is presented in Figure S7. (B) 
Immunofluorescence analyses in HaCaT and HEK293T cells transiently transfected 
with WT and mutant TGM3 encoding constructs are presented by images captured 
with 10x and 63x objectives. The analyses show clear differences in the number of 
cells producing the WT and mutant TGM3 (10x images). Scale bars, 50 µm and 10 
µm for 10x and 63x objectives, respectively. (C) Transglutaminase activity of WT and 
mutated TGM3 produced in HEK293T cells. Mock transfected cell lysates were used 
as negative control. The transglutaminase activity, represented by the mean slope of 
10-minute long measurements from technical triplicates (given in Figure S8), is 
presented as a dot plot. The enzymatic activity assay was performed with samples 
emerging from five independent transfections. Horizontal lines represent the mean 
values (mean ± SD; WT: 0.84±0.45; p.Gln451*: 0.10±0.04; mock: 0.07±0.02). Results 
demonstrate that the mutated protein did not differ from the mock transfected 
negative control in terms of activity and WT TGM3 had a significantly higher activity in 
comparison to both (*P<0.05, Dunn’s Test). 
34 
 
Table 1. Individuals carrying PADI3, TGM3 and TCHH mutations 
 
Country Gene Mutation Consequence  Clinical description 
United 
Kingdom 
PADI3 c.881C>T, homozygous p.Ala294Val This study 
Denmark PADI3 c.881C>T, homozygous p.Ala294Val 
Nissen and Svendsen 
2013 24 
Germany PADI3 c.335T>A, homozygous p.Leu112His This study 
Spain PADI3 c.881C>T, c.335T>A p.Ala294Val, p.Leu112His Novoa et al. 2012 25 
Germany PADI3 c.881C>T, c.335T>A p.Ala294Val, p.Leu112His This study 
Germany PADI3 c.881C>T, c.335T>A p.Ala294Val, p.Leu112His This study 
Germany PADI3 c.881C>T, c.1813C>A p.Ala294Val, p.Pro605Thr This study 
Germany PADI3 c.335T>A, c.1813C>A p.Leu112His, p.Pro605Thr This study 
Switzerland PADI3 c.881C>T, c.1732A>T  p.Ala294Val, p.Lys578* This study 
Turkey TGM3 c.1351C>T, homozygous p.Gln451* Kilic et al. 2013 26 
Germany TCHH c.991C>T, homozygous p.Gln331* This study 
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